Pathogenic role of B cells in the development of diffuse alveolar hemorrhage induced by pristane

Laboratory Investigation

Volumn 91, Issue 10, 2011, Pages 1540-1550

  Barker, Tolga T ^a   Lee, Pui Y ^a   Kelly Scumpia, Kindra M ^a   Weinstein, Jason S ^a   Nacionales, Dina C ^a   Kumagai, Yutaro ^b   Akira, Shizuo ^b   Croker, Byron P ^a   Sobel, Eric S ^a   Reeves, Westley H ^a   Satoh, Minoru ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

animal model; B cells; diffuse alveolar hemorrhage; pristane; systemic lupus erythematosus

Indexed keywords

FAS ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; PRISTANE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; IMMUNOPATHOGENESIS; LUNG HEMORRHAGE; LUPUS LIKE SYNDROME; MACROPHAGE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 80053367444     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.108     Document Type: Article

References (40)

1. Kamen DL, Strange C. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 2010;31:479-488.
2. Todd DJ, Costenbader KH. Dyspnoea in a young woman with active systemic lupus erythematosus. Lupus 2009;18:777-784.
3. Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 2000;118:1083-1090.
4. Zamora MR, Warner ML, Tuder R, et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997;76:192-202. (Pubitemid 27255822)
5. Badsha H, Teh CL, Kong KO, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2004;33:414-421. (Pubitemid 38887140)
6. Schwab EP, Schumacher Jr HR, Freundlich B, et al. Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 1993;23:8-15. (Pubitemid 23270889)
7. Desnoyers MR, Bernstein S, Cooper AG, et al. Pulmonary hemorrhage in lupus erythematosus without evidence of an immunologic cause. Arch Intern Med 1984;144:1398-1400. (Pubitemid 14087067)
8. Castaneda S, Herrero-Beaumont G, Aguado JM, et al. Pulmonary hemorrhage in lupus erythematosus without evidence of an immunologic cause. Arch Intern Med 1985;145:2128-2129.
9. Satoh M, Kumar A, Kanwar YS, et al. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci USA 1995;92:10934-10938.
10. Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994;180:2341-2346. (Pubitemid 24351616)
11. Wooley PH, Seibold JR, Whalen JD, et al. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989;32:1022-1030. (Pubitemid 19218382)
12. Lee PY, Kumagai Y, Li Y, et al. TLR7-dependent and FcgammaRindependent production of type I interferon in experimental mouse lupus. J Exp Med 2008;205:2995-3006.
13. Lee PY, Li Y, Kumagai Y, et al. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am J Pathol 2009;175:2023-2033.
14. Lee PY, Weinstein JS, Nacionales DC, et al. A novel type I IFN-producing cell subset in murine lupus. J Immunol 2008;180:5101-5108.
15. Nacionales DC, Kelly KM, Lee PY, et al. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl- pentadecane (pristane). Am J Pathol 2006;168:1227-1240.
16. Satoh M, Weintraub JP, Yoshida H, et al. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus. J Immunol 2000;165:1036-1043. (Pubitemid 30484774)
17. Chowdhary VR, Grande JP, Luthra HS, et al. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. Rheumatology (Oxford) 2007;46:1405-1410. (Pubitemid 47333620)
18. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003;301:640-643. (Pubitemid 36927946)
19. Satoh M, Hamilton K, Ajmani A, et al. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 1996;157:3200-3206. (Pubitemid 126450084)
20. Kirou KA, Lee C, George S, et al. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005;52:1491-1503. (Pubitemid 40663941)
21. Zhuang H, Narain S, Sobel E, et al. Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus. Clin Immunol 2005;117:238-250. (Pubitemid 43005210)
22. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995;16:39-43.
23. Montecino-Rodriguez E, Dorshkind K. New perspectives in B-1 B cell development and function. Trends Immunol 2006;27:428-433. (Pubitemid 44216193)
24. Hardy RR. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr Opin Immunol 2006;18:547-555. (Pubitemid 44311455)
25. Murakami M, Yoshioka H, Shirai T, et al. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol 1995;7:877-882.
26. Swigris JJ, Fischer A, Gillis J, et al. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest 2008;133:271-280.
27. Churg A, Franklin W, Chan KL, et al. Pulmonary hemorrhage and immune-complex deposition in the lung. Complications in a patient with systemic lupus erythematosus. Arch Pathol Lab Med 1980;104:388-391. (Pubitemid 10073591)
28. Mintz G, Galindo LF, Fernandez-Diez J, et al. Acute massive pulmonary hemorrhage in systemic lupus erythematosus. J Rheumatol 1978;5: 39-50.
29. Myers JL, Katzenstein AA. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986;85:552-556. (Pubitemid 16061121)
30. Satoh M, Richards HB, Shaheen VM, et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol 2000;121:399-405. (Pubitemid 30659782)
31. Vollmer J, Tluk S, Schmitz C, et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005;202:1575-1585. (Pubitemid 41746603)
32. Hamilton KJ, Satoh M, Swartz J, et al. Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus. Clin Immunol Immunopathol 1998;86: 271-279. (Pubitemid 28169458)
33. Kyttaris VC, Juang YT, Tsokos GC. Immune cells and cytokines in systemic lupus erythematosus: an update. Curr Opin Rheumatol 2005; 17:518-522. (Pubitemid 41527809)
34. Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat Rev Immunol 2010;10:236-247.
35. Anderton SM, Fillatreau S. Activated B cells in autoimmune diseases: the case for a regulatory role. Nat Clin Pract Rheumatol 2008;4: 657-666.
36. Haas KM, Watanabe R, Matsushita T, et al. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol 2010;184:4789-4800.
37. Browning JL. B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov 2006;5:564-576. (Pubitemid 43971191)
38. Nellessen CM, Poge U, Brensing KA, et al. Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report. Nephrol Dial Transplant 2008;23: 385-386. (Pubitemid 351767423)
39. Pinto LF, Candia L, Garcia P, et al. Effective treatment of refractory pulmonary hemorrhage with monoclonal anti-CD20 antibody (rituximab). Respiration 2009;78:106-109.
40. Narshi CB, Haider S, Ford CM, et al. Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus. Rheumatology (Oxford) 2010;49:392-394.